Clinical Trial Update: Ocular Safety and Usability Study for FYB203 PFS [Phase 4]

View source ↗

Summary

Phase 4 ocular safety and usability study of FYB203 PFS has completed, evaluating safety outcomes and usability in age-related macular degeneration and retinal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Branch Retinal Vein Occlusion with Macular Edema
• Central Retinal Vein Occlusion with Macular Edema
• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• FYB203 PFS

Snippet

Sponsor: Formycon AG | Conditions: Age-Related Macular Degeneration, Branch Retinal Vein Occlusion with Macular Edema | Phase 4 | Status: COMPLETED